Masimo's uSpO 2 ™ (pictured) is a "Board-in-Cable" external pulse oximetry solution that provides a simple way to add Masimo SET ® pulse oximetry for devices that are not designed to have SpO 2 ...

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today FDA clearance of Next Generation SedLine ® brain function monitoring. SedLine helps clinicians monitor the state of the brain ...

Masimo has made a name for itself as a prolific purveyor of noninvasive patient monitoring technologies, from the SET pulse oximeter to the recently CE-marked Rainbow SuperSensor, which continuously ...

Irvine, CA-based Masimo CorporationMASI recently announced the availability of the RD SedLine EEG sensor, which can be used with the company's flagship SedLine Brain Function Monitoring technology. In ...

Improved SpO 2 Accuracy Now Available for All Patient Populations IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today that RD SET ® sensors with Masimo Measure-through Motion and ...

Noting the unique nature of pediatric brains, which are still developing, the importance that standard anesthesia practice places on minimizing the dosage of drugs needed to maintain anesthesia, and ...

SedLine uses a pediatric-specific signal processing engine to improve performance of Masimo’s processed EEG parameter, the Patient State Index (PSi), when monitoring pediatric patients one year old ...

Masimo Corporation MASI received the FDA’s nod for its RD SET sensors to be used with Masimo Measure-through Motion and Low Perfusion SET pulse oximetry. The procedure is aimed at offering improved ...

Masimo has received 510(k) clearance to sell its next-generation brain function monitoring device. The FDA nod gives doctors an updated tool for monitoring the state of the brain in anesthetized and ...

Using less than 45 milliwatts of power, Masimo MS-2040 boards are available in both a double-stack version (pictured) with dimensions of 1.8″ x 1.15″ x 0.46″ and single-stack version with dimensions ...

Next Generation SedLine Now Available for Use on Patients 1-18 Years Old in CE Mark Countries NEUCHATEL, Switzerland — Masimo (NASDAQ: MASI) announced today the CE marking of Next Generation SedLine ® ...